生物
诱导多能干细胞
移植
胰岛素
干细胞
细胞生物学
体外
细胞疗法
细胞
细胞分化
分泌物
内科学
内分泌学
癌症研究
胚胎干细胞
生物化学
医学
基因
作者
Felicia W. Pagliuca,Jeffrey R. Millman,Mads Gürtler,Michael Segel,Alana Van Dervort,Jennifer Hyoje-Ryu Kenty,Quinn P. Peterson,Dale L. Greiner,Douglas A. Melton
出处
期刊:Cell
[Cell Press]
日期:2014-10-01
卷期号:159 (2): 428-439
被引量:2025
标识
DOI:10.1016/j.cell.2014.09.040
摘要
The generation of insulin-producing pancreatic β cells from stem cells in vitro would provide an unprecedented cell source for drug discovery and cell transplantation therapy in diabetes. However, insulin-producing cells previously generated from human pluripotent stem cells (hPSC) lack many functional characteristics of bona fide β cells. Here, we report a scalable differentiation protocol that can generate hundreds of millions of glucose-responsive β cells from hPSC in vitro. These stem-cell-derived β cells (SC-β) express markers found in mature β cells, flux Ca2+ in response to glucose, package insulin into secretory granules, and secrete quantities of insulin comparable to adult β cells in response to multiple sequential glucose challenges in vitro. Furthermore, these cells secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI